Sartorius Stedim Biotech/ FR0013154002 /
| 2024-04-26 5:00:39 PM | Chg. -1.85 | Volume | Bid2024-04-26 | Ask2024-04-26 | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 208.55EUR | -0.88% | 43 Turnover: 8,968.20 |
-Bid Size: - | -Ask Size: - | 19.2 bill.EUR | 0.33% | 61.99 |
Fundamentals
| FY 2023 | Growth (1Y) | |
|---|---|---|
| Per Share | ||
| Earnings per Share: | 3.36 EUR | -64.67% |
| EPS Diluted: | - EUR | -64.67% |
| Revenues per Share: | 30.11 EUR | -20.53% |
| Book Value per Share: | 28.62 EUR | 7.70% |
| Cash Flow per Share: | 8.10 EUR | 21.90% |
| Dividend per Share: | 0.69 EUR | -52.08% |
| Total | in mill. | |
| Revenues: | 2,775.50 EUR | -20.53% |
| Net Income: | 309.70 EUR | -64.65% |
| Operating Cash Flow: | 746.40 EUR | - |
| Cash and Cash Equivalents: | 116.60 EUR | - |
Valuation Ratios
| Current | Latest FY* | |
|---|---|---|
| P/E Ratio: | 61.99 | 71.28 |
| P/S Ratio: | 6.92 | 7.95 |
| P/BV ratio: | 7.28 | 8.37 |
| P/CF Ratio: | 25.73 | 29.58 |
| PEG: | -0.96 | -1.10 |
| Earnings Yield: | 1.61% | 1.40% |
| Dividend Yield: | 0.33% | 0.29% |
| Market Capitalization | ||
| Market Capitalization: | 19.2 bill. EUR | 22.08 bill. EUR |
| Free Float Market Cap.: | - EUR | - EUR |
| Market Cap. / Employee: | 1.8 mill. EUR | 2.07 mill. EUR |
| Shares Outstanding: | 92.18 mill. | |
Profitability
| Gross Profit Margin: | 44.44% |
| EBIT Margin: | 16.17% |
| Net Profit Margin: | 11.16% |
| Return on Equity: | 11.74% |
| Return on Assets: | 4.00% |
Financial Strength
| Liquidity I / Cash Ratio: | 12.44% |
| Liquidity II / Quick Ratio: | 43.77% |
| Liquidity III / Current Ratio: | 150.98% |
| Debt / Equity Ratio: | 193.41% |
| Dynam. Debt / Equity Ratio: | 683.55% |
Efficiency
| Employees: | 10,662 |
| Personal Expenses / Employee: | - EUR |
| Revenues / Employee: | 260,317.01 EUR |
| Net Income / Employee: | 29,047.08 EUR |
| Total Assets / Employee: | 725,933.22 EUR |
| * Fiscal Year End: | 2023-12-31 |
| Accounting Standard: | IFRS |
| Currency: | EUR |
